Inside the human eye, the retina is made up of several types of cells, including the light-sensing photoreceptors that ...
Eye diseases often develop asymptomatically for many years. ICTER scientists have developed the f-ORG technique, which ...
Insights shed light on what the approval means for providers and their patients affected by this neurodegenerative retinal ...
Coronary artery disease, CAD, is a condition where the arteries that supply blood to the heart muscle become clogged and narrow, making it difficult for blood and oxygen to reach the muscles of ...
Central retinal artery occlusion (CRAO) is an ophthalmological emergency. Various treatment modalities have been tried, but none have shown to alter natural history of the disease. Hyperoxia can ...
The Food and Drug Administration (FDA) has approved Encelto (revakinagene taroretcel-lwey) for the treatment of macular telangiectasia type 2 (MacTel).
Encelto™ is an allogeneic encapsulated cell-based gene therapy designed to slow retinal degeneration in MacTel patients. It works by delivering continuous ciliary neurotrophic factor (CNTF)-a protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results